EUVIMEDEUVIMED entdecken
Crossref

Cardiac Safety of COVID-19 Vaccines

Mayuko Sorimachi, Osamu Manabe, Kazuya Shizukuishi, Hiroshi Shibata, Kazunori Kubota, Noriko Oyama-Manabe

Annals of Nuclear Cardiology · 2026 · 12 (1) · 18-23

DOI: 10.17996/anc.25-00009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Nuclear Cardiology, 2026. Verfasst von Mayuko Sorimachi und 5 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of this study was to assess myocardial metabolic activity and cardiac function in asymptomatic health checkup subjects before and after COVID-19 vaccination.

Methods

We retrospectively analyzed clinical records of 67 asymptomatic subjects who underwent whole-body 18 F-fluorodeoxyglucose (FDG) positron emission tomography / computed tomography before and after COVID-19 vaccination.Cardiac metabolic activity was assessed using myocardial standardized uptake value (SUVmax).Echocardiography and cardiac magnetic resonance imaging (MRI), including cine-based strain analysis, were used to evaluate cardiac function.The Wilcoxon signed-rank test and Bland-Altman plots were applied to assess changes between pre-and post-vaccination data.

Results

No significant differences in myocardial FDG uptake (SUVmax: 3.29 [interquartile ranges : 2.84-6.45]vs. 3.21 [IQR: 2.76-7.25],P=0.63) was observed.Similarly, echocardiographic parameters, including left ventricular ejection fraction, left ventricular end-diastolic volume, and left ventricular end-systolic volume, remained unchanged.MRI-based circumferential strain also showed no significant alterations (-21.27±3.63 vs. -21.90±3.60,P=0.088).

Conclusions

This study, the first to systematically evaluate myocardial FDG uptake alongside MRI strain analysis in the same subjects pre-and post-vaccination, suggests that vaccination is not associated with meaningful changes in myocardial metabolic activity or cardiac function.These findings lend support to the cardiac safety of COVID-19 vaccination and provide a robust basis for future research in broader populations.

Zitieren

APA

Sorimachi, M., Manabe, O., Shizukuishi, K., Shibata, H., Kubota, K., & Oyama-Manabe, N. (2026). Cardiac Safety of COVID-19 Vaccines. Annals of Nuclear Cardiology, 12(1), 18-23. https://doi.org/10.17996/anc.25-00009

Vancouver

Sorimachi M, Manabe O, Shizukuishi K, Shibata H, Kubota K, Oyama-Manabe N. Cardiac Safety of COVID-19 Vaccines. Annals of Nuclear Cardiology. 2026;12(1):18-23. doi:10.17996/anc.25-00009

BibTeX
@article{Sorimachi2026,
  author = {Sorimachi, Mayuko and Manabe, Osamu and Shizukuishi, Kazuya and Shibata, Hiroshi and Kubota, Kazunori and Oyama-Manabe, Noriko},
  title = {Cardiac Safety of COVID-19 Vaccines},
  journal = {Annals of Nuclear Cardiology},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {18--23},
  doi = {10.17996/anc.25-00009}
}
Kostenlos starten →